Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Wellola is a digital health company focused on patient engagement, care communication, and digital care pathway software for healthcare providers. Its flagship platform, Portasana, is used by NHS and other healthcare organizations to support appointments, letters, messaging, forms, symptom tracking, remote monitoring, surveys, and condition-specific care journeys. The company was founded in Ireland in 2016 by Sonia Neary and Dr Greg Martin and expanded into the UK in 2019. Wellola has positioned itself as a clinician-built, interoperable healthtech vendor helping providers shift care into community and remote settings. In March 2026, Wellola joined Mayden, indicating that it now operates as part of a larger digital health group.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Wellola.